Transplant minus immunosuppressants boosts insulin in study

10/29/2013 | Bloomberg

A study in the Proceedings of the National Academy of Sciences revealed a senior type 1 diabetes patient who received a beta-cell transplant showed signs of insulin production for 10 months. However, researchers found that the procedure, which used a device to eliminate the need for immunosuppressant drugs, resulted in only slight improvements in the patient's blood glucose levels.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD